Skip to Content

2,633 Results Found

  • Article
  • Open Access
1 Citations
791 Views
25 Pages

Accurate Segmentation of Overlapping Cervical Cells Using an Optimized Deep Learning Framework for Cytology Screening

  • Amal A. Alzu’bi,
  • Mohammad Khatatbeh,
  • Wan Azani Mustafa,
  • Norhayati Mohd Zain and ,
  • Hiam Alquran,
  • Alia Al-Mohtaseb,
  • Khaled Z. Alawneh,
  • Mohammad Fawaeer,
  • Bara’a Fawaeer and
  • Ahmad Alhussain
  • + 6 authors+ 1 author

Background: Cervical cancer remains one of the leading causes of cancer-related morbidity among women worldwide. The Papanicolaou (Pap) smear is widely used for early detection; however, its manual interpretation is time-consuming, requires substanti...

(This article belongs to the Special Issue AI and Digital Health for Disease Diagnosis and Monitoring, 2nd Edition)
  • Article
  • Open Access
7 Citations
2,910 Views
16 Pages

18 March 2024

To address the issue of low accuracy in detecting defects of battery cell casings with low space ratio and small object characteristics, the low space ratio feature and small object feature are studied, and an object detection algorithm based on dual...

(This article belongs to the Special Issue Manufacturing Processes: Enhancements through Smart and Sustainable Approaches)
  • Article
  • Open Access
4 Citations
7,275 Views
9 Pages

Biochip-Based Detection of KRAS Mutation in Non-Small Cell Lung Cancer

  • Gernot Kriegshäuser,
  • Gerhild Fabjani,
  • Barbara Ziegler,
  • Sabine Zöchbauer-Müller and ,
  • Adelheid End and
  • Robert Zeillinger
  • + 1 author+ 0 author

29 November 2011

This study is aimed at evaluating the potential of a biochip assay to sensitively detect KRAS mutation in DNA from non-small cell lung cancer (NSCLC) tissue samples. The assay covers 10 mutations in codons 12 and 13 of the KRAS gene, and is based on...

(This article belongs to the Special Issue Advances in Molecular Diagnostics)
  • Review
  • Open Access
7 Citations
3,821 Views
13 Pages

Neuroendocrine-Related Circulating Transcripts in Small-Cell Lung Cancers: Detection Methods and Future Perspectives

  • Lucia Anna Muscarella,
  • Tommaso Mazza,
  • Federico Pio Fabrizio,
  • Angelo Sparaneo and ,
  • Vito D’Alessandro,
  • Antonio Tancredi,
  • Domenico Trombetta,
  • Flavia Centra,
  • Silvana Pia Muscarella and
  • Antonio Rossi
  • + 6 authors+ 1 author

16 March 2021

No well-established prognostic or predictive molecular markers of small-cell lung cancer (SCLC) are currently available; therefore, all patients receive standard treatment. Adequate quantities and quality of tissue samples are frequently unavailable...

(This article belongs to the Special Issue Neuroendocrine Neoplasms: Current Challenges and Advances in the Biological Aspects, Diagnostic and Therapeutic Management)
  • Article
  • Open Access
2 Citations
2,645 Views
13 Pages

26 October 2022

Plasma cell-free DNA (cfDNA) sequencing data have been widely studied for early diagnosis and treatment response or recurrence monitoring of cancers because of the non-invasive benefits. In cancer studies, whole exome sequencing (WES) is mostly used...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
6 Citations
3,032 Views
13 Pages

Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor pro...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
10 Citations
2,661 Views
14 Pages

Detection of Small Targets in Photovoltaic Cell Defect Polarization Imaging Based on Improved YOLOv7

  • Haixia Wang,
  • Fangbin Wang,
  • Xue Gong,
  • Darong Zhu and ,
  • Ruinan Wang and
  • Ping Wang
  • + 1 author+ 0 author

2 May 2024

A photovoltaic cell defect polarization imaging small target detection method based on improved YOLOv7 is proposed to address the problem of low detection accuracy caused by insufficient feature extraction ability in the process of small target defec...

  • Article
  • Open Access
4 Citations
3,681 Views
13 Pages

29 March 2024

Gold nanoparticles (AuNPs) exhibit improved optical and spectral properties compared to bulk materials, making them suitable for the detection of DNA, RNA, antigens, and antibodies. Here, we describe a simple, selective, and rapid non-cross linking d...

(This article belongs to the Section Biosensor Materials)
  • Article
  • Open Access
52 Citations
6,916 Views
15 Pages

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET

  • Menno Tamminga,
  • Kiki C. Andree,
  • T. Jeroen N. Hiltermann,
  • Maximilien Jayat and ,
  • Ed Schuuring,
  • Hilda van den Bos,
  • Diana C. J. Spierings,
  • Peter M. Lansdorp,
  • Wim Timens and
  • Harry J. M. Groen
  • + 6 authors+ 1 author

7 April 2020

Circulating tumor cells (CTCs) detected by CellSearch are prognostic in non-small-cell lung cancer (NSCLC), but rarely found. CTCs can be extracted from the blood together with mononuclear cell populations by diagnostic leukapheresis (DLA), therefore...

(This article belongs to the Special Issue Liquid Biopsy: Latest Advances and Future Challenges)
  • Article
  • Open Access
15 Citations
4,438 Views
14 Pages

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer

  • Wenzhe Li,
  • Ling Zhu,
  • Kaidi Li,
  • Siyuan Ye and ,
  • Huayi Wang,
  • Yadong Wang,
  • Jianchao Xue,
  • Chen Wang,
  • Shanqing Li and
  • Yanlian Yang
  • + 6 authors+ 1 author

28 February 2022

Small extracellular vesicles (sEVs) carry molecular information from their source cells and are desired biomarkers for cancer diagnosis. We establish a machine learning-assisted dual-marker detection method to analyze the expression of epidermal grow...

(This article belongs to the Special Issue Applications of Nanomaterials for Biological Analysis)
  • Review
  • Open Access
8 Citations
4,414 Views
14 Pages

Can Tumour Antigens Act as Biomarkers for the Early Detection of Non-Small Cell Lung Cancer?

  • Eithar Mohamed,
  • Daniel Fletcher,
  • Simon Hart and
  • Barbara-ann Guinn

31 May 2024

Lung cancer (LC) is one of the leading causes of cancer-related deaths. Pulmonary nodules are one of the risk factors, and their discovery rate has been increasing due to enhanced performance of chest CT scans, but more than 90% are non-malignant, ca...

  • Review
  • Open Access
35 Citations
10,073 Views
24 Pages

15 October 2021

Globally, non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths. Despite advancements in chemotherapy and targeted therapies, the 5-year survival rate has remained at 16% for the past forty years. Minimal residual disease (MRD) is...

(This article belongs to the Special Issue Immunosensors - Trends and Perspective)
  • Article
  • Open Access
20 Citations
5,043 Views
20 Pages

Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR

  • Christiane Stiller,
  • Kristina Viktorsson,
  • Elizabeth Paz Gomero,
  • Petra Hååg and ,
  • Vasiliki Arapi,
  • Vitaliy O. Kaminskyy,
  • Caroline Kamali,
  • Luigi De Petris,
  • Simon Ekman and
  • Amelie Eriksson Karlström
  • + 6 authors+ 1 author

22 February 2021

Precision cancer medicine for non-small-cell lung cancer (NSCLC) has increased patient survival. Nevertheless, targeted agents towards tumor-associated membrane receptors only result in partial remission for a limited time, calling for approaches whi...

(This article belongs to the Special Issue The Impact of Extracellular Vesicles in Cancer Progression and Diagnosis)
  • Article
  • Open Access
15 Citations
2,969 Views
12 Pages

Changes in Staging and Management of Non-Small Cell Lung Cancer (NSCLC) Patients Following the Implementation of Low-Dose Chest Computed Tomography (LDCT) Screening at Kaohsiung Medical University Hospital

  • Chin-Ling Chen,
  • Jui-Sheng Hsu,
  • Yi-Wen Shen,
  • Chih-Hsiang Hsu and ,
  • Shih-Yu Kao,
  • Wei-An Lai,
  • Cheng-Hao Chuang,
  • Yu-Wei Liu,
  • Jui-Ying Lee and
  • Chih-Jen Yang
  • + 8 authors+ 3 authors

5 November 2024

Background: Low-dose computed tomography (LDCT) has been widely adopted for lung cancer screening due to its proven ability to reduce lung cancer mortality, especially among high-risk populations. Methods: This retrospective study aims to evaluate th...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
30 Citations
9,088 Views
14 Pages

Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer

  • David R. Hout,
  • Brock L. Schweitzer,
  • Kasey Lawrence,
  • Stephan W. Morris and ,
  • Tracy Tucker,
  • Rosetta Mazzola,
  • Rachel Skelton,
  • Frank McMahon,
  • John Handshoe and
  • David L. Saltman
  • + 7 authors+ 2 authors

1 August 2017

Patients with lung cancers harboring an activating anaplastic lymphoma kinase (ALK) rearrangement respond favorably to ALK inhibitor therapy. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) are validated and widely used scree...

(This article belongs to the Special Issue Targeting ALK in Cancer)
  • Article
  • Open Access
5 Citations
3,471 Views
10 Pages

Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients

  • Elisa Boldrin,
  • Giorgia Nardo,
  • Elisabetta Zulato,
  • Laura Bonanno and ,
  • Valentina Polo,
  • Stefano Frega,
  • Alberto Pavan,
  • Stefano Indraccolo and
  • Daniela Saggioro
  • + 4 authors+ 0 author

Liquid biopsy is currently approved for management of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) patients. However, one unanswered question is whether the rate of cell-free DNA (cfDNA)-negative samples is due t...

(This article belongs to the Collection Feature Papers in Molecular Oncology)
  • Article
  • Open Access
19 Citations
4,465 Views
16 Pages

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Maria A. Papadaki,
  • Ippokratis Messaritakis,
  • Oraianthi Fiste,
  • John Souglakos and ,
  • Eleni Politaki,
  • Athanasios Kotsakis,
  • Vassilis Georgoulias,
  • Dimitrios Mavroudis and
  • Sofia Agelaki
  • + 4 authors+ 0 author

We herein investigated the detection frequency and clinical relevance of circulating tumor cells (CTCs) in chemotherapy-naïve stage IIIB/IV non-small cell lung cancer (NSCLC), by using the CellSearch and real-time CEACAM5mRNA assays. Blood sampl...

(This article belongs to the Special Issue Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics 2.0)
  • Article
  • Open Access
22 Citations
4,369 Views
13 Pages

Template-Assisted Plasmonic Nanogap Shells for Highly Enhanced Detection of Cancer Biomarkers

  • Homan Kang,
  • Sinyoung Jeong,
  • Jin-Kyoung Yang,
  • Ahla Jo and ,
  • Hyunmi Lee,
  • Eun Hae Heo,
  • Dae Hong Jeong,
  • Bong-Hyun Jun,
  • Hyejin Chang and
  • Yoon-Sik Lee
  • + 5 authors+ 0 author

10 February 2021

We present a template-assisted method for synthesizing nanogap shell structures for biomolecular detections based on surface-enhanced Raman scattering. The interior nanogap-containing a silver shell structure, referred to as a silver nanogap shell (A...

(This article belongs to the Special Issue Metal Nano/Microparticles for Bioapplications)
  • Review
  • Open Access
3 Citations
1,946 Views
23 Pages

Blood-Based miRNA Panels for Timely Detection of Non-Small-Cell Lung Cancer: From Biomarker Discovery to Clinical Translation

  • Yazan Zedan,
  • Maria Yurievna Konoshenko,
  • Olga Evgenievna Bryzgunova,
  • Antonina Aleksandrovna Ilyushchenko and ,
  • Yaroslava Mikhailovna Danilova,
  • Stanislav Dmitrievich Gorbunkov,
  • Kirill Alekseevich Zykov and
  • Pavel Petrovich Laktionov
  • + 3 authors+ 0 author

14 December 2025

Lung cancer (LC) remains a leading cause of global cancer mortality, driving the need for novel timely detection strategies, i.e., stages I–II detection when tumor curation is efficient. Circulating microRNA (miRNAs), with their unique stabilit...

(This article belongs to the Special Issue Molecular Perspectives in Lung Diseases: Pathogenesis, Diagnosis, and Treatment)
  • Review
  • Open Access
59 Citations
14,322 Views
16 Pages

12 August 2017

Patients with advanced-stage non-small cell lung carcinoma (NSCLC) harboring an ALK rearrangement, detected from a tissue sample, can benefit from targeted ALK inhibitor treatment. Several increasingly effective ALK inhibitors are now available for t...

(This article belongs to the Special Issue Targeting ALK in Cancer)
  • Article
  • Open Access
11 Citations
6,108 Views
20 Pages

Multiplex Droplet Digital PCR Assay for Detection of MET and HER2 Genes Amplification in Non-Small Cell Lung Cancer

  • Igor P. Oscorbin,
  • Maria A. Smertina,
  • Ksenia A. Pronyaeva,
  • Mikhail E. Voskoboev and ,
  • Ulyana A. Boyarskikh,
  • Andrey A. Kechin,
  • Irina A. Demidova and
  • Maxim L. Filipenko
  • + 3 authors+ 0 author

11 March 2022

Non-small-cell lung cancer (NSCLC), a subtype of lung cancer, remains one of the most common tumors with a high mortality and morbidity rate. Numerous targeted drugs were implemented or are now developed for the treatment of NSCLC. Two genes, HER2 an...

(This article belongs to the Special Issue Advances in Prognosis and Theranostics of Lung Cancer)
  • Article
  • Open Access
5 Citations
3,568 Views
14 Pages

Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome

  • Malaïka Van der Linden,
  • Bram Van Gaever,
  • Lennart Raman,
  • Karim Vermaelen and ,
  • Ingel Demedts,
  • Veerle Surmont,
  • Ulrike Himpe,
  • Yolande Lievens,
  • Liesbeth Ferdinande and
  • Jo Van Dorpe
  • + 9 authors+ 4 authors

18 April 2022

Diagnosis of lung cancer requires histological examination of a tissue sample, which in turn requires an invasive procedure that cannot always be obtained. Circulating tumor DNA can be reliably detected in blood samples of advanced-stage lung cancer...

(This article belongs to the Special Issue Cell-Free DNA as Prognostic and Predictive Biomarker in Solid Cancers)
  • Review
  • Open Access
52 Citations
11,814 Views
24 Pages

Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer

  • Misty Dawn Shields,
  • Kevin Chen,
  • Giselle Dutcher,
  • Ishika Patel and
  • Bruna Pellini

12 August 2022

Advancements in the clinical practice of non-small cell lung cancer (NSCLC) are shifting treatment paradigms towards increasingly personalized approaches. Liquid biopsies using various circulating analytes provide minimally invasive methods of sampli...

(This article belongs to the Special Issue Liquid Biopsies in Oncology)
  • Article
  • Open Access
2 Citations
1,217 Views
17 Pages

17 November 2025

Circulating cell-free DNA (cfDNA) sequencing offers a minimally invasive approach for profiling tumor genomes, but detecting copy number alterations (CNAs) from cfDNA whole-exome sequencing (WES) remains technically challenging due to noise and guani...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
257 Views
20 Pages

Clinical Artificial Intelligence in Non-Small Cell Lung Cancer: From Early Detection and Computational Pathology to Precision Oncology

  • Luca Bertolaccini,
  • Matteo Chiari,
  • Sara Degiovanni,
  • Antonio Mazzella and ,
  • Giorgio Lo Iacono,
  • Juliana Guarize,
  • Monica Casiraghi and
  • Lorenzo Spaggiari
  • + 3 authors+ 0 author

22 October 2026

Artificial intelligence (AI) is being developed to analyze radiological, histopathological, molecular, and clinical data across the non-small cell lung cancer (NSCLC) pathway. This narrative review examines representative applications through August...

(This article belongs to the Special Issue Clinical Pathology of Lung Cancer (2nd Edition))
  • Article
  • Open Access
31 Citations
5,236 Views
18 Pages

Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer

  • Kleita Michaelidou,
  • Chara Koutoulaki,
  • Konstantinos Mavridis,
  • Eleftherios Vorrias and ,
  • Maria A. Papadaki,
  • Anastasios V. Koutsopoulos,
  • Dimitrios Mavroudis and
  • Sofia Agelaki
  • + 3 authors+ 0 author

20 November 2020

KRAS mutations are found in approximately one third of non-small cell lung cancer (NSCLC) patients. In this study, we aim to investigate whether KRAS G12/G13 mutant allele fraction (MAF) in cell-free DNA (cfDNA) can provide meaningful prognostic info...

(This article belongs to the Special Issue Liquid Biopsy)
  • Article
  • Open Access
10 Citations
3,483 Views
15 Pages

Real-Time Impedance Detection for PEM Fuel Cell Based on TAB Converter Voltage Perturbation

  • Jialong Zhou,
  • Jinhai Jiang,
  • Fulin Fan,
  • Chuanyu Sun and ,
  • Zhen Dong and
  • Kai Song
  • + 1 author+ 0 author

29 August 2024

Fuel cells, as clean and efficient energy conversion devices, hold great potential for applications in the fields of hydrogen-based transportation and stand-alone power systems. Due to their sensitivity to load parameters, environmental parameters, a...

(This article belongs to the Special Issue Renewable Energy and Hydrogen Energy Technologies)
  • Article
  • Open Access
28 Citations
6,322 Views
15 Pages

GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer

  • Hyesun Jeong,
  • Byeong Hyeon Choi,
  • JinA Park,
  • Jik-Han Jung and ,
  • Hyunku Shin,
  • Ka-Won Kang,
  • Yu Hua Quan,
  • Jewon Yu,
  • Ji-Ho Park and
  • Sunghoi Hong
  • + 8 authors+ 3 authors

31 October 2021

No specific markers have been identified to detect non-small cell lung cancer (NSCLC) cell-derived exosomes circulating in the blood. Here, we report a new biomarker that distinguishes between cancer and non-cancer cell-derived exosomes. Exosomes iso...

(This article belongs to the Collection Cancer Biomarkers)
  • Article
  • Open Access
4 Citations
4,004 Views
12 Pages

Sentinel Lymph Node Mapping in Lung Cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell Lung Cancer

  • Gaetano Romano,
  • Carmelina Cristina Zirafa,
  • Fabrizia Calabrò,
  • Greta Alì and ,
  • Gianpiero Manca,
  • Annalisa De Liperi,
  • Agnese Proietti,
  • Beatrice Manfredini,
  • Iosè Di Stefano and
  • Franca Melfi
  • + 8 authors+ 3 authors

15 May 2024

Lymphadenectomy represents a fundamental step in the staging and treatment of non-small cell lung cancer (NSCLC). To date, the extension of lymphadenectomy in early-stage NSCLC is a debated topic due to its possible complications. The detection of se...

(This article belongs to the Section Cancer Imaging)
  • Article
  • Open Access
26 Citations
4,782 Views
21 Pages

Multimodal Lung Cancer Subtyping Using Deep Learning Neural Networks on Whole Slide Tissue Images and MALDI MSI

  • Charlotte Janßen,
  • Tobias Boskamp,
  • Jean Le’Clerc Arrastia,
  • Daniel Otero Baguer and ,
  • Lena Hauberg-Lotte,
  • Mark Kriegsmann,
  • Katharina Kriegsmann,
  • Georg Steinbuß,
  • Rita Casadonte and
  • Peter Maaß
  • + 6 authors+ 1 author

14 December 2022

Artificial intelligence (AI) has shown potential for facilitating the detection and classification of tumors. In patients with non-small cell lung cancer, distinguishing between the most common subtypes, adenocarcinoma (ADC) and squamous cell carcino...

(This article belongs to the Special Issue Advances in Mass Spectrometry Imaging-Based Cancer Research)
  • Article
  • Open Access
34 Citations
1,395 Views
9 Pages

MicroRNA Expression Profiling of Sputum for the Detection of Early and Locally Advanced Non-Small-Cell Lung Cancer: A Prospective Case–Control Study

  • R. Razzak,
  • E.L.R. Bédard,
  • J.O. Kim,
  • S. Gazala and ,
  • L. Guo,
  • S. Ghosh,
  • A. Joy,
  • T. Nijjar,
  • E. Wong and
  • W.H. Roa
  • + 5 authors+ 0 author

1 April 2016

Background: Non-small-cell lung cancer (NSCLC) is associated with very poor overall survival because 70% of patients present with locally advanced or metastatic disease at the time of diagnosis. MicroRNAS (miRNAS) are a class of short, noncoding RNA...

  • Article
  • Open Access
10 Citations
3,973 Views
11 Pages

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer

  • Ye-Rin Kim,
  • Ki-Uk Kim,
  • Jung-Hee Lee,
  • Deok-Won Kim and ,
  • Jae-Heun Chung,
  • Yeong-Dae Kim,
  • Dong-Hoon Shin,
  • Min-Ki Lee,
  • Yong-Il Shin and
  • Sang-Yull Lee
  • + 5 authors+ 0 author

20 May 2021

To identify cancer/testis (CT) antigens and immunogenic proteins, immunoscreening of testicular and small-cell lung cancer cell line NCI-H889 cDNA libraries was performed using serum obtained from a small-cell lung cancer (SCLC) patient. We obtained...

  • Article
  • Open Access
850 Views
20 Pages

Identification of von Willebrand Factor-Enriched Small Extracellular Vesicles as a Blood-Based Biomarker for the Detection of Head and Neck Squamous Cell Carcinoma

  • Yue Su,
  • Kekoolani S. Visan,
  • Sunyoung Ham,
  • Xuanxuan Li and ,
  • Su-Ho Park,
  • Cherrie W. K. Ng,
  • Judy Wai Ping Yam,
  • Jason Y. K. Chan and
  • Andreas Möller
  • + 4 authors+ 0 author

20 July 2026

Background: Head and neck squamous cell carcinoma (HNSCC) remains a major global health challenge due to the lack of effective and non-invasive diagnostic tools, often resulting in late-stage detection of cancer. Small extracellular vesicles (sEVs) h...

(This article belongs to the Topic Biomarker Development and Application, 2nd Edition)
  • Article
  • Open Access
4 Citations
3,009 Views
13 Pages

High Incidence of False Positives in EGFR S768I Mutation Detection Using the Idylla qPCR System in Non-Small Cell Lung Cancer Patients

  • Miguel Carnero-Gregorio,
  • Enzo Perera-Gordo,
  • Vanesa de-la-Peña-Castro,
  • Jesús María González-Martín and ,
  • Julio José Delgado-Sánchez and
  • Carmen Rodríguez-Cerdeira
  • + 1 author+ 0 author

Background/Objectives: The accurate detection of EGFR mutations, particularly the rare S768I variant, is crucial for guiding treatment decisions in non-small cell lung cancer (NSCLC) patients. This study investigated the incidence of false positives...

(This article belongs to the Special Issue Lung Cancer: Screening, Diagnosis and Management)
  • Article
  • Open Access
5 Citations
3,465 Views
17 Pages

Clinical Validation of Plasma Metabolite Markers for Early Lung Cancer Detection

  • Lun Zhang,
  • Jiamin Zheng,
  • Rashid A. Bux,
  • Jean-François Haince and ,
  • Claudia Torres-Calzada,
  • Rupasri Mandal,
  • Andrew Maksymiuk,
  • Guoyu Huang,
  • Paramjit S. Tappia and
  • David S. Wishart
  • + 7 authors+ 2 authors

Early detection of lung cancer significantly improves survival, yet current screening methods have limitations. This study aimed to identify a robust panel of plasma metabolites for early-stage non-small cell lung cancer (NSCLC) diagnosis using a lar...

(This article belongs to the Special Issue Molecular Pathogenesis and Diagnostics of Lung Diseases)
  • Article
  • Open Access
13 Citations
4,853 Views
14 Pages

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

  • Paul van der Leest,
  • Melanie Janning,
  • Naomi Rifaela,
  • Maria L. Aguirre Azpurua and ,
  • Jolanthe Kropidlowski,
  • Sonja Loges,
  • Nicolas Lozano,
  • Alexander Sartori,
  • Darryl Irwin and
  • Ed Schuuring
  • + 11 authors+ 6 authors

29 August 2023

Analysis of circulating tumor DNA (ctDNA) is a potential minimally invasive molecular tool to guide treatment decision-making and disease monitoring. A suitable diagnostic-grade platform is required for the detection of tumor-specific mutations with...

(This article belongs to the Special Issue Mass Spectrometry in Molecular Biology)
  • Review
  • Open Access
701 Views
16 Pages

29 August 2026

Molecular residual disease (MRD) testing approaches with plasma next-generation sequencing (NGS) testing to identify circulating tumor DNA (ctDNA) in resectable-stage non-small cell lung cancer (NSCLC) are evolving. The MRD concept is to better guide...

(This article belongs to the Special Issue Cell-Free Nucleic Acids as Precision Biomarkers for Therapeutic Decision-Making Across Diseases)
  • Article
  • Open Access
6 Citations
3,679 Views
15 Pages

Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients

  • Javier Simarro,
  • Gema Pérez-Simó,
  • Nuria Mancheño,
  • Emilio Ansotegui and ,
  • Carlos Francisco Muñoz-Núñez,
  • José Gómez-Codina,
  • Óscar Juan and
  • Sarai Palanca
  • + 3 authors+ 0 author

In pretreatment tumor samples of EGFR-mutated non-small cell lung cancer (NSCLC) patients, EGFR-Thr790Met mutation has been detected in a variable prevalence by different ultrasensitive assays with controversial prognostic value. Furthermore, its det...

(This article belongs to the Special Issue Frontiers in Lung Cancer: Immune Modulation and Targeted Therapies)
  • Review
  • Open Access
33 Citations
4,481 Views
22 Pages

Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer

  • Kalliopi Andrikou,
  • Tania Rossi,
  • Alberto Verlicchi,
  • Ilaria Priano and ,
  • Paola Cravero,
  • Marco Angelo Burgio,
  • Lucio Crinò,
  • Sara Bandini,
  • Paola Ulivi and
  • Angelo Delmonte
  • + 5 authors+ 0 author

8 November 2023

Non-small cell lung cancer (NSCLC) is one of the deadliest diseases worldwide. Tissue biopsy is the current gold standard for the diagnosis and molecular profiling of NSCLC. However, this approach presents some limitations due to inadequate tissue sa...

(This article belongs to the Special Issue Circulating Tumor Cells, Liquid Biopsies, and Precision Oncology)
  • Article
  • Open Access
52 Citations
7,527 Views
25 Pages

Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer

  • Fayez Kheir,
  • Mengmeng Zhao,
  • Michael J. Strong,
  • Yi Yu and ,
  • Asuka Nanbo,
  • Erik K. Flemington,
  • Gilbert F. Morris,
  • Krzysztof Reiss,
  • Li Li and
  • Zhen Lin
  • + 5 authors+ 0 author

31 May 2019

Previous investigations proposed a link between the Epstein-Barr virus (EBV) and lung cancer (LC), but the results are highly controversial largely due to the insufficient sample size and the inherent limitation of the traditional viral screening met...

(This article belongs to the Special Issue Application of Next-Generation Sequencing in Cancers)
  • Case Report
  • Open Access
5 Citations
1,026 Views
2 Pages

Thoracic Ultrasound for the Detection of Rib Metastases of Non-Small Cell Lung Cancer

  • Ioannis Tomos,
  • Nikos Tziolos,
  • Thomas Raptakis and
  • Dimitra Kavatha

30 April 2018

Transthoracic ultrasound has lately emerged as a useful diagnostic tool for respiratory physicians in the diagnosis of diverse pulmonary diseases, usually including pleural effusion and pneumothorax. However, the use of chest ultrasound may be also c...

  • Article
  • Open Access
71 Citations
7,175 Views
14 Pages

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics

  • Hugo Arasanz,
  • Miren Zuazo,
  • Ana Bocanegra,
  • María Gato and ,
  • Maite Martínez-Aguillo,
  • Idoia Morilla,
  • Gonzalo Fernández,
  • Berta Hernández,
  • Paúl López and
  • David Escors
  • + 11 authors+ 6 authors

4 February 2020

Hyperprogressive disease (HPD) is an adverse outcome of immunotherapy consisting of an acceleration of tumor growth associated with prompt clinical deterioration. The definitions based on radiological evaluation present important technical limitation...

  • Article
  • Open Access
4 Citations
7,694 Views
11 Pages

14 May 2022

The study aimed to demonstrate rapid and effective molecular testing on liquid-based cytology (LBC) samples for EGFR, KRAS and BRAF mutations using the Biocartis Idylla™. Rapid on-site evaluation (ROSE) LBC samples for patients with non-small c...

(This article belongs to the Collection Feature Papers in Journal of Molecular Pathology)
  • Article
  • Open Access
24 Citations
10,879 Views
11 Pages

Economic Analysis of Alternative Strategies for Detection of ALK Rearrangements in Non Small Cell Lung Cancer

  • Shivang Doshi,
  • David Ray,
  • Karen Stein,
  • Jie Zhang and ,
  • Prasad Koduru,
  • Franz Fogt,
  • Axel Wellman,
  • Ricky Wat and
  • Charles Mathews
  • + 4 authors+ 0 author

Identification of alterations in ALK gene and development of ALK-directed therapies have increased the need for accurate and efficient detection methodologies. To date, research has focused on the concordance between the two most commonly used techno...

  • Article
  • Open Access
1 Citations
2,106 Views
10 Pages

Development of a Novel IHC Assay for PD-L1 Detection in Non-Small Cell Lung Cancer

  • Faye Willett,
  • Marie MacLennan,
  • Sihem Khelifa,
  • Bharathi Vennapusa and ,
  • Hannah Gautrey,
  • Michael Parkin,
  • Kate R Wilson,
  • Kieran O’Toole,
  • Shubham Dayal and
  • Fangru Lian
  • + 7 authors+ 2 authors

26 September 2025

Background/Objectives: Programmed cell death-ligand 1 (PD-L1) is one of the key biomarkers for immune checkpoint inhibitors. We are developing a novel PD-L1 CAL10 immunohistochemistry (IHC) assay (Leica Biosystems) on BOND-III staining system and hav...

(This article belongs to the Section Immunology and Immunotherapy)
  • Review
  • Open Access
39 Citations
4,485 Views
15 Pages

Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients

  • Evangelia Pantazaka,
  • Vasileios Vardas,
  • Argyro Roumeliotou,
  • Stavros Kakavogiannis and
  • Galatea Kallergi

29 April 2021

Lung cancer is the leading cause of cancer-related mortality globally. Among the types of lung cancer, non-small-cell lung cancer (NSCLC) is more common, while small-cell lung cancer (SCLC) is less frequent yet more aggressive. Circulating tumor cell...

(This article belongs to the Special Issue Chemical Modulation and Analytical Detection of Cancer Stem Cells, Circulating Tumour Cells, and Other Non-bulk Cancer Cell Types)
  • Review
  • Open Access
46 Citations
6,316 Views
20 Pages

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?

  • Fiorella Calabrese,
  • Francesca Lunardi,
  • Federica Pezzuto,
  • Francesco Fortarezza and ,
  • Stefania Edith Vuljan,
  • Charles Marquette and
  • Paul Hofman
  • + 2 authors+ 0 author

26 March 2019

Lung cancer is one of the most lethal malignancies worldwide, mainly due to its late diagnoses. The detection of molecular markers on samples provided from routine bronchoscopy including several liquid-based cytology tests (e.g., bronchoaspirate, bro...

(This article belongs to the Special Issue Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis)
  • Article
  • Open Access
44 Citations
8,044 Views
13 Pages

CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients

  • Hao Peng,
  • Lan Lu,
  • Zisong Zhou,
  • Jian Liu and ,
  • Dadong Zhang,
  • Kejun Nan,
  • Xiaochen Zhao,
  • Fugen Li,
  • Lei Tian and
  • Yu Yao
  • + 6 authors+ 1 author

14 November 2019

While methods for detecting SNVs and indels in circulating tumor DNA (ctDNA) with hybridization capture-based next-generation sequencing (NGS) have been available, copy number variations (CNVs) detection is more challenging. Here, we present a method...

(This article belongs to the Special Issue Selected Papers from the International Conference on Intelligent Biology and Medicine (ICIBM 2019))
  • Article
  • Open Access
2 Citations
3,267 Views
16 Pages

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients

  • Lei Cao,
  • Zhili Cao,
  • Hongsheng Liu,
  • Naixin Liang and ,
  • Zhongxing Bing,
  • Caijuan Tian and
  • Shanqing Li
  • + 2 authors+ 0 author

15 August 2022

Microsatellite instability (MSI), high tumor mutation burden (TMB-H) and programmed cell death 1 ligand 1 (PD-L1) expression are hot biomarkers related to the improvement of immunotherapy response. Two cohorts of non-small-cell lung cancer (NSCLC) we...

  • Communication
  • Open Access
3 Citations
2,683 Views
7 Pages

Our study optimized METex14 skipping mutation detection by analyzing 223 Oncomine™ Focus Assay-positive cases using Pan Lung Cancer PCR Panel and reverse transcription (RT)-PCR. Among the 11 METex14 skipping mutation-positive cases (average rea...

(This article belongs to the Section Pathology and Molecular Diagnostics)

of 53